Radius Health Inc (RDUS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Radius Health Inc (RDUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9802
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Radius Health Inc (Radius Health), formerly NuVios, Inc., is a biopharmaceutical company that develops and commercializes therapeutics for osteoporosis, oncology and endocrine diseases. The company’s product includes abaloparatide injection, which is used for the treatment of postmenopausal women with osteoporosis. Its clinical programs include abaloparatide-SC subcutaneous injection for osteoporosis, abaloparatide-TD transdermal patch for osteoporosis, RAD1901 oral for vasomotor symptoms, RAD1901 oral for breast cancer brain metastases, and RAD140 for cachexia or frailty or breast cancer. The company also develops drugs for reproductive disorders. It operates in Waltham, Parsippany, Wayne and Cambridge, the US. Radius Health is headquartered in Waltham, Massachusetts, the US.

Radius Health Inc (RDUS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Radius Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Radius Health Inc, Medical Devices Deals, 2012 to YTD 2018 10
Radius Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Radius Health Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Radius Health Raises US$43 Million In Venture Financing 12
Partnerships 14
Radius Health Partners with Novartis Pharma for RAD1901 14
Radius Health Enters Into Collaboration Agreement With 3M Drug Delivery Systems 15
Licensing Agreements 16
Radius Health Enters into Licensing Agreement with Duke University 16
Teijin Enters into Licensing Agreement with Radius Health 17
Equity Offering 18
Radius Health Raises USD345 Million in Public Offering of Shares 18
Radius Health Raises USD169 Million in Public Offering of Shares 20
Radius Health Raises USD57.1 Million in Public Offering of Shares 22
Radius Health Raises USD52 Million in IPO of Shares 24
Debt Offering 26
Radius Health Raises USD300 Million in Public Offering of 3% Convertible Notes Due 2024 26
Acquisition 28
Shire May Acquire Radius Health 28
Radius Health Inc – Key Competitors 29
Radius Health Inc – Key Employees 30
Radius Health Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Financial Announcements 32
Nov 01, 2018: Radius Health announces third quarter 2018 operating results and financial guidance for FY 2018 and FY 2019 32
Aug 07, 2018: Radius Health announces second quarter 2018 financial results 35
May 10, 2018: Radius Health Reports First Quarter 2018 Financial and Operating Results and Provides Business Update 38
Mar 01, 2018: Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update 41
Nov 02, 2017: Radius Health Reports Third Quarter 2017 Financial and Operating Results and Provides Business Update 44
May 01, 2017: Radius Health Reports First Quarter 2017 Financial and Operating Results 47
Feb 23, 2017: Radius Health Reports Fourth Quarter and Full Year 2016 Financial and Operating Results 49
Corporate Communications 52
Sep 04, 2018: Radius Health names Dr Charles Morris as Chief Medical Officer 52
Jul 16, 2018: Radius Health appoints Chhaya Shah as senior vice president of technical operations 53
Jul 17, 2017: Radius Health Appoints Jesper Høiland as President and Chief Executive Officer To Lead The Next Stage Of Growth and Value Creation As A Fully Integrated Commercial Biotech Company 54
May 15, 2017: Radius Health Appoints Pharmaceutical Executive Jose Carmona as Chief Financial Officer 56
Product News 57
03/31/2017: Radius Health Presents Data on Pipeline drug RAD140 at the 2017 American Association for Cancer Research Annual Meeting (AACR) 57
Clinical Trials 58
Sep 29, 2017: Radius Health Initiates Phase 1 Clinical Trial of RAD140 for the Treatment of Hormone Receptor Positive Breast Cancer 58
Mar 31, 2017: Radius Health Presents Preclinical Data on Elacestrant (RAD1901) at the 2017 American Association for Cancer Research Annual Meeting (AACR) 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
Radius Health Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Radius Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Radius Health Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Radius Health Inc, Medical Devices Deals, 2012 to YTD 2018 10
Radius Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Radius Health Raises US$43 Million In Venture Financing 12
Radius Health Partners with Novartis Pharma for RAD1901 14
Radius Health Enters Into Collaboration Agreement With 3M Drug Delivery Systems 15
Radius Health Enters into Licensing Agreement with Duke University 16
Teijin Enters into Licensing Agreement with Radius Health 17
Radius Health Raises USD345 Million in Public Offering of Shares 18
Radius Health Raises USD169 Million in Public Offering of Shares 20
Radius Health Raises USD57.1 Million in Public Offering of Shares 22
Radius Health Raises USD52 Million in IPO of Shares 24
Radius Health Raises USD300 Million in Public Offering of 3% Convertible Notes Due 2024 26
Shire May Acquire Radius Health 28
Radius Health Inc, Key Competitors 29
Radius Health Inc, Key Employees 30
Radius Health Inc, Other Locations 31
Radius Health Inc, Subsidiaries 31

List of Figures
Radius Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Radius Health Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Radius Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Radius Health Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Radius Health Inc (RDUS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Network Rail Ltd:企業の戦略的SWOT分析
    Network Rail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • AZTherapies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary AZTherapies Inc (AZTherapies) is a clinical-stage drug development company that offers discovery, development and commercialization of novel Alzheimer’s disease therapeutics. The company’s product pipeline includes the lead product candidate ALZT-OP1, besides ALZT-Patch, ALZT-QoL, AZHALER-D …
  • Ircon International Limited:企業の戦略・SWOT・財務情報
    Ircon International Limited - Strategy, SWOT and Corporate Finance Report Summary Ircon International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Panariagroup Industrie Ceramiche SpA:企業の戦略・SWOT・財務情報
    Panariagroup Industrie Ceramiche SpA - Strategy, SWOT and Corporate Finance Report Summary Panariagroup Industrie Ceramiche SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Petro Vista Energy Corp (PTV.H):石油・ガス:M&Aディール及び事業提携情報
    Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and production of oil and gas properties. It offers upstream oil and gas services with exploration and produ …
  • Theravasc Inc-製薬・医療分野:企業M&A・提携分析
    Summary Theravasc Inc (Theravasc) is a healthcare services provider that develops treatments for various chronic medical diseases using oral formulation of sodium nitrite. The company’s product TV1001SR is a coated oral formulation of sodium nitrite for the treatment of peripheral artery diseases an …
  • Peakdale Molecular Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Peakdale Molecular Ltd (Peakdale), a subsidiary of Concept Life Sciences Ltd, is a company that offers drug discovery services. It service portfolio offers services including drug discovery, nucleoside chemistry, materials chemistry and research support services. Peakdale offers research sup …
  • Servair:企業の戦略・SWOT・財務情報
    Servair - Strategy, SWOT and Corporate Finance Report Summary Servair - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Ingosstrakh Joint-Stock Insurance Company Ltd.:企業の戦略・SWOT・財務分析
    Ingosstrakh Joint-Stock Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ingosstrakh Joint-Stock Insurance Company Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析
    Summary Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological ca …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sanofi SA:戦略・SWOT・企業財務分析
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Oneok Inc (OKE):石油・ガス:M&Aディール及び事業提携情報
    Summary Oneok Inc (ONEOK) is an oil and gas company that processes, gathers, storages and transports natural gas. The company's products include natural gas and natural gas liquids. It offers services such as natural gas, natural gas pipelines, and natural gas liquids gathering, processing, marketin …
  • JSS Medical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary JSS Medical Research Inc (JSS) is a contract research organization which offers clinical research services. It provides clinical trial services in various therapeutic areas that include cardiovascular disorders, oncology, infectious disease, neurology and psychiatry, autoimmune disorders, re …
  • Koninklijke Philips N.V. (PHIA)-製薬・医療分野:企業M&A・提携分析
    Summary Koninklijke Philips N.V. (Philips) is a diversified technology company which focuses on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. The company develops and manufactures medical …
  • TH Heavy Engineering Berhad (THHEAVY):企業の財務・戦略的SWOT分析
    TH Heavy Engineering Berhad (THHEAVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • Groupe SEB S.A. (SK):企業の財務・戦略的SWOT分析
    Groupe SEB S.A. (SK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆